New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Launois
P
P
WHO Immunology Research and Training Center, Institute of Biochemistry,University of Lausanne, Switzerland.
Himmelrich
H
H
Tacchini-Cottier
F
F
Milon
G
G
Louis
J A
JA
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D002454:Cell Differentiation; D004198:Disease Susceptibility / Q000276:immunology*; D018664:Interleukin-12 / Q000276:immunology*; D015847:Interleukin-4 / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D018320:Leishmania major / Q000276:immunology*; D016773:Leishmaniasis, Cutaneous / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D015800:Protozoan Proteins / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology*
D000953:Antigens, Protozoan; D015800:Protozoan Proteins; D016693:Receptors, Antigen, T-Cell, alpha-beta; C093139:LACK antigen, Leishmania; D018664:Interleukin-12; D015847:Interleukin-4